BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: An D, Peigneur S, Hendrickx LA, Tytgat J. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. Int J Mol Sci 2020;21:E5064. [PMID: 32709050 DOI: 10.3390/ijms21145064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Srichana T, Chunhachaichana C, Suedee R, Sawatdee S, Changsan N. Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants. J Drug Deliv Sci Technol 2022;76:103805. [PMID: 36159727 DOI: 10.1016/j.jddst.2022.103805] [Reference Citation Analysis]
2 Lima LS, Loyola V, Bicca JVML, Faro L, Vale CLC, Lotufo Denucci B, Mortari MR. Innovative treatments for epilepsy: Venom peptides, cannabinoids, and neurostimulation. J Neurosci Res 2022. [PMID: 35934922 DOI: 10.1002/jnr.25114] [Reference Citation Analysis]
3 Moody MT, Ringel MM, Mathews CM, Midthun KM. Determination of Cross-Reactivity of Contemporary Cannabinoids with THC Direct Immunoassay (ELISA) in Whole Blood. J Anal Toxicol 2022:bkac051. [PMID: 35867546 DOI: 10.1093/jat/bkac051] [Reference Citation Analysis]
4 Lee H, Tamia G, Song H, Amarakoon D, Wei C, Lee S. Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells. International Immunopharmacology 2022;108:108865. [DOI: 10.1016/j.intimp.2022.108865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Martínez-Peña AA, Petrik JJ, Hardy DB, Holloway AC. Delta-9-tetrahydrocannabinol increases vascular endothelial growth factor (VEGF) secretion through a cyclooxygenase-dependent mechanism in rat granulosa cells. Reprod Toxicol 2022:S0890-6238(22)00064-8. [PMID: 35588954 DOI: 10.1016/j.reprotox.2022.05.004] [Reference Citation Analysis]
6 Shirai N, Choudhary S, Houle C. Gastric Neuroendocrine Tumors With Parietal Cell Atrophy in a Long-term Carcinogenicity Study in Rats. Toxicol Pathol 2022;:1926233221095445. [PMID: 35510893 DOI: 10.1177/01926233221095445] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lin X, Xu Z, Carey L, Romero J, Makriyannis A, Hillard CJ, Ruggiero E, Dockum M, Houk G, Mackie K, Albrecht PJ, Rice FL, Hohmann AG. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. Pain 2021. [PMID: 35001054 DOI: 10.1097/j.pain.0000000000002502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Santos S, Barata P, Charmier A, Lehmann I, Rodrigues S, Melosini MM, Pais PJ, Sousa AP, Teixeira C, Santos I, Rocha AC, Baylina P, Fernandes R. Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy. Front Immunol 2022;13:841459. [PMID: 35242142 DOI: 10.3389/fimmu.2022.841459] [Reference Citation Analysis]
9 El-atawneh S, Goldblum A. Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors. Front Pharmacol 2022;13:812745. [DOI: 10.3389/fphar.2022.812745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mahmoudinoodezh H, Telukutla SR, Bhangu SK, Bachari A, Cavalieri F, Mantri N. The Transdermal Delivery of Therapeutic Cannabinoids. Pharmaceutics 2022;14:438. [DOI: 10.3390/pharmaceutics14020438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 An D, Pinheiro-junior EL, Béress L, Gladkikh I, Leychenko E, Undheim EAB, Peigneur S, Tytgat J. AsKC11, a Kunitz Peptide from Anemonia sulcata, Is a Novel Activator of G Protein-Coupled Inward-Rectifier Potassium Channels. Marine Drugs 2022;20:140. [DOI: 10.3390/md20020140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Park YM, Dahlem C, Meyer MR, Kiemer AK, Müller R, Herrmann J. Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism. Molecules 2022;27:1290. [PMID: 35209079 DOI: 10.3390/molecules27041290] [Reference Citation Analysis]
13 Dutta S, Selvam B, Shukla D. Distinct Binding Mechanisms for Allosteric Sodium Ion in Cannabinoid Receptors. ACS Chem Neurosci 2022;13:379-89. [PMID: 35019279 DOI: 10.1021/acschemneuro.1c00760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Hryhorowicz S, Kaczmarek-Ryś M, Zielińska A, Scott RJ, Słomski R, Pławski A. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review. Front Immunol 2021;12:790803. [PMID: 35003109 DOI: 10.3389/fimmu.2021.790803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Lee YE, Nakashima Y, Kodama T, Chen X, Morita H. Dual Engineering of Olivetolic Acid Cyclase and Tetraketide Synthase to Generate Longer Alkyl-Chain Olivetolic Acid Analogs. Org Lett 2021. [PMID: 34939812 DOI: 10.1021/acs.orglett.1c04089] [Reference Citation Analysis]
16 Apweiler M, Streyczek J, Saliba SW, Ditrich J, Muñoz E, Fiebich BL. Anti-Inflammatory and Anti-Oxidative Effects of AM404 in IL-1β-Stimulated SK-N-SH Neuroblastoma Cells. Front Pharmacol 2021;12:789074. [PMID: 34867421 DOI: 10.3389/fphar.2021.789074] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Kicman A, Pędzińska-Betiuk A, Kozłowska H. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases. Eur J Pharmacol 2021;911:174560. [PMID: 34648805 DOI: 10.1016/j.ejphar.2021.174560] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Filipiuc LE, Ababei DC, Alexa-Stratulat T, Pricope CV, Bild V, Stefanescu R, Stanciu GD, Tamba BI. Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? Pharmaceutics 2021;13:1823. [PMID: 34834237 DOI: 10.3390/pharmaceutics13111823] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
19 Visvanathar R, Papanikolaou M, Nôga DA, Pádua-Reis M, Tort ABL, Blunder M. Hippocampal Cb2 receptors: an untold story. Rev Neurosci 2021. [PMID: 34717053 DOI: 10.1515/revneuro-2021-0109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Rabino M, Mallia S, Castiglioni E, Rovina D, Pompilio G, Gowran A. The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases. Pharmaceuticals (Basel) 2021;14:936. [PMID: 34577636 DOI: 10.3390/ph14090936] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Ghit A, Assal D, Al-Shami AS, Hussein DEE. GABAA receptors: structure, function, pharmacology, and related disorders. J Genet Eng Biotechnol 2021;19:123. [PMID: 34417930 DOI: 10.1186/s43141-021-00224-0] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
22 Hallinan CM, Eden E, Graham M, Greenwood LM, Mills J, Popat A, Truong L, Bonomo Y. Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group. J Psychopharmacol 2021;:2698811211035394. [PMID: 34344208 DOI: 10.1177/02698811211035394] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Hashiesh HM, Sharma C, Goyal SN, Jha NK, Ojha S. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist. Front Pharmacol 2021;12:702675. [PMID: 34393784 DOI: 10.3389/fphar.2021.702675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhirnov VV, Velihina YS, Mitiukhin OP, Brovarets VS. Intrinsic drug potential of oxazolo[5,4-d]pyrimidines and oxazolo[4,5-d]pyrimidines. Chem Biol Drug Des 2021. [PMID: 34148293 DOI: 10.1111/cbdd.13911] [Reference Citation Analysis]
25 Morris G, Walder K, Kloiber S, Amminger P, Berk M, Bortolasci CC, Maes M, Puri BK, Carvalho AF. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks. Pharmacol Res 2021;170:105729. [PMID: 34119623 DOI: 10.1016/j.phrs.2021.105729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Kaabi JA, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid. Biomed Pharmacother 2021;140:111639. [PMID: 34091179 DOI: 10.1016/j.biopha.2021.111639] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
27 Scheau C, Caruntu C, Badarau IA, Scheau AE, Docea AO, Calina D, Caruntu A. Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier. J Pers Med 2021;11:494. [PMID: 34072930 DOI: 10.3390/jpm11060494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
28 An D, Peigneur S, Tytgat J. WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels. Biomedicines 2021;9:484. [PMID: 33924979 DOI: 10.3390/biomedicines9050484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Pagano C, Navarra G, Coppola L, Bifulco M, Laezza C. Molecular Mechanism of Cannabinoids in Cancer Progression. Int J Mol Sci 2021;22:3680. [PMID: 33916164 DOI: 10.3390/ijms22073680] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
30 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yu Y, Chen W, Meng D, Zhou XM, Wang LL, Xu C. A Cannabinoid-1 Receptor Antagonist MJ08 with Different Effects in Stomach and Small Intestine. Assay Drug Dev Technol 2021;19:176-83. [PMID: 33784479 DOI: 10.1089/adt.2020.1041] [Reference Citation Analysis]
32 Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. Toxins (Basel) 2021;13:117. [PMID: 33562446 DOI: 10.3390/toxins13020117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
33 Cankara FN, Çelik ZB, Günaydın C. Cannabinoid receptors modulate LPS-induced increase of class-II transactivator expression levels in a microglial cell line. J Recept Signal Transduct Res 2021;41:209-16. [PMID: 33401964 DOI: 10.1080/10799893.2020.1868510] [Reference Citation Analysis]
34 Xin Q, Xu F, Taylor DH, Zhao JF, Wu J. The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders. Acta Pharmacol Sin 2020;41:1507-18. [PMID: 33024239 DOI: 10.1038/s41401-020-00530-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Morales P, Bruix M, Jiménez MA. Structural Insights into β-arrestin/CB1 Receptor Interaction: NMR and CD Studies on Model Peptides. Int J Mol Sci 2020;21:E8111. [PMID: 33143110 DOI: 10.3390/ijms21218111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]